NHS GRAMPIAN MRSA POLICY FOR COMMUNITY SETTINGS JUNE 2003

Size: px
Start display at page:

Download "NHS GRAMPIAN MRSA POLICY FOR COMMUNITY SETTINGS JUNE 2003"

Transcription

1 NHS GRAMPIAN MRSA POLICY FOR COMMUNITY SETTINGS JUNE 2003 Grampian NHS Board Grampian University Hospitals Trust Grampian Primary Care Trust

2 TABLE OF CONTENTS Aim 3 1 Introduction 4 2 Control of MRSA in the community Safe Working Practice Isolation Screening Household contacts/ residents in care 5 homes Staff 5 3 Treatment / Decolonisation Patients discharged form hospital Residents/ Individuals diagnosed in the community 6 4 Treatment of infection and decolonisation protocol Treatment of MRSA infection Treatment for infected wounds Decolonisation of MRSA Decolonisation of normal skin Decolonisation of abnormal skin Colonised wounds Decolonisation of nasal carriage Decolonisation for throat carriage in adults Decolonisation for throat carriage for children 8 and neonates 4.10 Urine 9 5 Transfer to hospital or other care homes Communication Ambulance transportation 9 6 Communication Residents Staff 10 7 Care of deceased residents 10 Appendix 1 Contact personnel 11 Appendix 2 Screening 12 Appendix 3 Swabbing Techniques 13 Appendix 4 Detection and testing of MRSA 14 Appendix 5 Discharge, Admission Information/communication 15 Appendix 6 Patient Information Leaflet 17 Appendix 7 Staff Information Leaflet 19 Appendix 8 Definitions 21 2

3 AIM This policy aims to ensure effective, appropriate management of MRSA positive individuals in community settings in Grampian. THIS POLICY MUST NOT BE ALTERED IN ANY WAY. IF YOU HAVE ANY CONCERNS REGARDING THE SUITABILITY OR APPLICATION OF ANY OF THE FOLLOWING POLICY CONTACT YOUR LOCAL INFECTION CONTROL TEAM (LISTED IN APPENDIX 1) INFECTION CONTROL TRAINING FOR CARE HOMES IS AVAILABLE FROM THE PUBLIC HEALTH INFECTION CONTROL NURSES HEALTH PROTECTION TEAM NHS GRAMPIAN

4 1 INTRODUCTION Approximately 30% of the population carry the organism Staphylococcus aureus (S. aureus). This is a bacterium, which is normally found in the nose and on skin. Most healthy people are unaffected by it, however it does have the potential to cause infection in those who have severely weakened immune systems. MRSA (Methicillin Resistant Staphylococcus aureus) is a form of S. aureus. It is transmitted in the same way, and causes the same range of infections as other strains of S. aureus, however it has developed resistance to the more commonly used antibiotics. This makes infections caused by MRSA more difficult and costly to treat, which is why every effort must be made to prevent its spread. The majority of individuals are COLONISED which is when the organism lives harmlessly on the body with no ill effects as opposed to INFECTED which is when the organism enters tissue and causes disease. Further definitions can be found in Appendix 8. In order to control and minimise the spread of MRSA there must be compliance with the following: Standard Precautions (formerly known as Universal Infection Control Precautions) Cleaning (domestic etc) must be of an acceptable standard Adherence to Infection Control Policies i.e. Clinical Waste, Laundry etc Infection control training Strict adherence to antibiotic policies Adequate resources for compliance Increasingly there are a number of individuals in the community who have acquired MRSA. MRSA is essentially a hospital problem. There are a number of reasons for this: Invasive procedures are frequently carried out in hospitals, which is an important route of infection. Hospitalised patients have lowered resistance to infection. There is widespread use of antibiotics in hospital People affected by MRSA do not present a risk to the community at large and should continue their normal lives without restriction. Many individuals are discharged into Care Homes and this should pose no problem to their ongoing care or that of the other residents as long as a few basic precautions are taken. 4

5 2 CONTROL OF MRSA IN THE COMMUNITY 2.1 Safe working practice NHS GRAMPIAN SAFE WORKING PRACTICE INFECTION CONTROL DOCUMENT MUST BE USED IN CONJUNCTION WITH THIS DOCUMENT Staff should adhere to the NHS Grampian Safe Working Practice Infection Control in the Community document, which is based around the principle of Standard Precautions (previously known as Universal Infection Control Precautions). These precautions should be applied to all residents at all times irrespective of diagnosis. This document should be located with each organisation s Infection Control documentation. All sections of the Safe Working Practice Infection Control guidelines should be applied. Additional guidance for use with patients/individuals with MRSA Laundry Individuals with MRSA do not need to have their laundry washed separately. If possible a biological pre-wash or detergent should be used with the hottest temperature suitable for the fabric. Cutlery and Crockery Cutlery and crockery requires no special treatment and can be washed in the sink or dishwasher with other items. Cleaning and Disinfection As per the organisation s agreed local Infection Control Policy. 2.2 Isolation There is no need to isolate residents to their own room if they have MRSA. It is preferable although not essential for residents who have MRSA to have a single room or be cohort nursed with other affected residents. 2.3 Screening Household contacts / Residents There is normally no need to screen household contacts or other residents in care homes for MRSA. For further advice discuss with appropriate infection control team. (See screening protocol Appendix 2 and swabbing technique Appendix 3) Staff 5

6 It is not necessary for work colleagues or carers to be screened for MRSA. 3 TREATMENT/ DECOLONISATION 3.1 Patients discharged from hospital When patients are discharged from hospital back into the community (including care homes) they may still be undergoing treatment for MRSA infection. This should be continued. When patients are discharged from hospital back into the community (including care homes) they may still be undergoing decolonisation for MRSA. This should be continued as per the protocol (see 4.3.3) If the post discharge decolonisation is unsuccessful. The individual should be assessed and usually one further attempt to decolonise the individual should be undertaken if: It is known or is likely that the individual will be admitted to hospital in the foreseeable future The individual has no invasive devises e.g. catheter The individuals skin is intact The individual does not have a skin condition e.g. eczema Further advice should be sought from the Infection Control Team of the discharge hospital (Appendix 1) if the individual has: Invasive devises e.g. catheter Broken skin Skin conditions e.g. eczema 3.2 Residents/Individuals diagnosed in the community Individuals with clinical infection caused by MRSA should always be treated promptly as with any other infection. If the individual is receiving systemic antibiotics these should be completed before undertaking a full MRSA screen. A full MRSA screen should be undertaken 48 hours after treatment is complete, to establish which sites are still positive (see Appendix 2). Individuals who are colonised with MRSA will not generally require decolonisation unless it is known or is likely that the individual will be admitted to hospital in the foreseeable future. Discuss with the GP/Infection Control Team. Further advice may be sought from the appropriate Infection Control Team (Appendix 1) 4. TREATMENT OF INFECTION AND DECOLONISATION PROTOCOL It is essential that current local policy be adhered to however in the unlikely event of any adverse reaction please stop the treatment and seek advice promptly. 6

7 4.1 Treatment of MRSA infection Patients who demonstrate clinical signs of infection will require treatment with the appropriate antibiotics. The agent used will depend on the site of infection. If the individual is receiving systemic antibiotics these should be completed before undertaking a full MRSA screen. Once treatment is complete, a full MRSA screen should be undertaken after 48 hours to establish which sites, if any, are still positive (see Appendix 2). Advice can always be obtained from Medical Microbiologist (Appendix1). It is important that the treatment should be based on the current set of full MRSA screening swabs. It is easier for both patients and staff if the treatment for the identified sites all commence at the same time 4.2 Treatment for infected wounds Where possible all wounds should be covered with an occlusive dressing Advice on appropriate systemic antibiotics should be sought from the Medical Microbiologist. Important: Do not apply topical treatments to acute infected surgical wounds 4.3 Decolonisation of MRSA Appropriate decolonisation should be considered when the patient s clinical condition allows. Once decolonisation is complete, a full MRSA screen should be undertaken after 48 hours to establish which sites, if any, are still positive (see Appendix 2). The eradication procedure used will depend upon which body sites are colonised with MRSA. Site Nasal carriage only Throat carriage Axilla or groin carriage Action Nasal decolonisation only Nasal and throat decolonisation Nasal and body decolonisation 4.4 Decolonisation of NORMAL skin Skin products should not be diluted. Infection Control Team Advice can be sought from the appropriate 1 st Line Direct application of 4% chlorhexidine (Hibiscrub) to all skin using a damp disposable cloth or freshly laundered flannel, daily for 5 7

8 days i.e. use chlorhexidine as a soap substitute and rinse off. Wash hair twice in the 5-day period with chlorhexidine. Alternatives include 2% triclosan (aquasept) or 7.5% povidine-iodine. Hair conditioners and body lotions can be used after treatment if required. 4.5 Decolonisation of ABNORMAL skin As it is difficult to eradicate MRSA from abnormal and/or chronic skin conditions, the decolonisation protocol should not be commenced until advice has been sought from a dermatologist or medical microbiologist. 4.6 Colonised wounds Seek advice from Infection Control or Tissue Viability Team. 4.7 Decolonisation of nasal carriage 1 st Line Mupirocin ( Bactroban ) nasal ointment 3 times daily to inner surface of each nostril for 5 days. Apply with cotton wool bud In the event of mupirocin resistance: Naseptin cream (0.5% neomycin plus 0.1% chlorhexidine) provided the organism is neomycin susceptible. Further advice can be sought from Infection Control Team (Appendix 1) 4.8 Decolonisation for throat carriage in adults Oral hygiene is very important, as teeth/dentures have been known to harbour MRSA. 1 st Line adults - Oral trimethoprim 200mg twice daily and 500mg fusidic acid tablets twice daily for 5 days. If using fusidic acid liquid, 750mg twice daily for 5 days. In the event of fusidic acid resistance or patient intolerance: Oral rifampicin 600mg once daily and trimethoprim 200mg twice daily (if susceptible) for 5 days. Patients may require an anti-emetic. 4.9 Decolonisation for throat carriage for children and neonates Before treating children and neonates advice must be sought from the Medical Microbiologist (Appendix 1) 8

9 4.10 Urine Elimination of MRSA from urine is not usually possible in the presence of a urinary catheter. If treatment is required discuss with the Medical Microbiologist and the clinician managing the patient. 5 TRANSFER TO HOSPITAL OR OTHER CARE HOMES 5.1 Communication If a resident is to be re-admitted to hospital please ensure that the receiving ward/unit are fully aware that the patient has had MRSA in the past. This will ensure that the hospital can take appropriate precautions (Appendix 5) If a resident is being transferred please ensure the receiving care home are fully aware of the residents MRSA status if known. 5.2 Ambulance transportation The Scottish Ambulance Service classifies patients who are MRSA positive into two categories. Category 1 Most patients colonised by MRSA or who have infected wounds or skin lesions which are covered by an occlusive dressing may be transported with others and require no special precautions. Category 2 Patients, who are heavily colonised by MRSA and are considered to be heavy shedders, eg have severe psoriasis or eczema. Patients who have infected exposed wounds or skin lesions, eg external fixation devices, burns etc should be transported by themselves. Patients who are clinically infected Patients who are colonised in the upper respiratory tract and present with active symptoms, eg cough Patients in category 2 should not be transported with others. The Ambulance Service will implement appropriate precautions applicable to this category. 6 COMMUNICATION Ensuring good communication about a resident s MRSA status is a responsibility of all staff. 6.1 Residents 9

10 Residents found to be colonised or infected with MRSA should be informed of this. The resident and their visitors should have MRSA explained to them. A patient/relative information sheet is available (Appendix 6) 6.2 Staff A staff information leaflet is available (Appendix 7) For further information contact the appropriate Infection Control Team. 7. CARE OF DECEASED RESIDENTS The precautions for handling these patients are the same as when alive (i.e. Standard Precautions (formerly known as Universal Infection Control Precautions) Lesions should be covered with an impermeable dressing Body (cadaver) bags are not necessary since there is no risk to healthy contacts unless the deceased patient has extensive burns, skin loss and/or extensive discharging wounds There are no contraindications for Last Offices including viewing 10

11 Appendix 1 CONTACT PERSONNEL Organisation Name & Title Number NURSING Grampian University Hospitals Trust ARI, Foresterhill Woodend Hospital Grampian University Hospital Trust (Dr Grays) & Grampian Primary Care Trust (Moray) Grampian Primary Care Trust Anne Smith, Infection Control Nurse Diane Pacitti, Infection Control Nurse Frances Murray, Infection Control Nurse Hilarie Fryer, Infection Control Nurse Roy Browning Infection Control Nurse Louise McBeath Infection Control Nurse Ext Bleep Ext Bleep Ext Bleep Switchboard Ext Bleep: NHS Grampian, Health Protection Summerfield House 2 Eday Road Aberdeen AB15 6RE Fiona Browning, Public Health Infection Control Nurse Jayne Leith, Public Health Infection Control Nurse Ext Ext MEDICAL (Microbiology) Grampian University Hospitals Trust & Grampian Primary Care Trust (Aberdeen & Elgin) Foresterhill, Aberdeen (Public Health) Health Protection Team Summerfield House 2 Eday Road Aberdeen AB15 6RE Dr T M S Reid, Consultant Microbiologist Dr I M Gould, Consultant Microbiologist Dr Helen Howie, Consultant in Public Health Medicine (CD&EH) Dr Arun Mukerjee, Consultant in Public Health Medicine (CD&EH) Switchboard Ext Ext Ext Ext

12 Appendix 2 SCREENING TECHNIQUE: Swabs should be moistened with sterile saline and rubbed firmly over the area to be screened. Send promptly to the Microbiology Laboratory. Label as Known MRSA screening swabs MRSA Swab Sites 1. If MRSA is initially identified from a routine swab or specimen, i.e. urine, wound, etc., then a full MRSA screen should be undertaken. (Send as known MRSA ) A B 2. A full screen includes the following:- A) Nasal swab (where suitable, use one swab for both nostrils) B) Throat swab (back of throat) C) Axillae (use ONE swab only for left and right) D) Groin (use ONE swab only for left and right) C The following should also be included as part of a full screen (if applicable):- E) Individual wounds/lesions or abnormal skin (e.g. eczema), also include peg/ gastrostomy sites. F) A CSU (if patient catheterized). G) Please label all swabs accurately and consistently including description and site. 3. Once a full screen has been undertaken to establish MRSA status DO NOT undertake further swabbing until MRSA treatment or decolonisation has been undertaken. D 4. Post-treatment swabbing should commence at least 48 hours after treatment/decolonisation has finished. This comprises of three full MRSA screens at least 48 hours apart (GUHT 1 st results must be negative before 2 nd and 3 rd sets are taken). 5. Once three consecutive full MRSA post-treatment screens are identified as negative (all individual swabs) then a patient is deemed CLEAR of MRSA. Please make sure that clearance of MRSA is confirmed by Microbiology or the Infection Control team. 6. Please allow at least three working days for results. 12

13 Appendix 3 SWABBING TECHNIQUES Nasal swab Nose Dip the swab in sterile saline/water and swab round both nostrils using the same swab. Throat Rub the back of the throat firmly with a swab. (Do not swab other areas of the mouth unless requested). Throat Swab Throat Rub the back of the throat firmly with a swab. (Do not swab other areas of the mouth unless requested) Axillae / Groin Using a non-touch technique, dip the swab in sterile saline/water and swab the area required. One swab can be used for both axillae and another swab for both groins. Wounds Dip the swab in sterile saline/water, then zig-zag and rotate it across the wound. Do not let the swab touch the surrounding skin. Send a sample of exudate or pus if present. Clearly identify the wound type, location, etc. Use the same identification details each time e.g. sacral sore left buttock Abnormal Skin (e.g. eczema, etc) Dip the swab in sterile saline/water then rotate the swab over the abnormal skin area. Clearly identify the abnormal skin area (i.e. type, site, etc). Use the same identification details each time. 13

14 Appendix 4 DETECTION AND TESTING OF MRSA MRSA Screen Each specimen is processed individually Plate onto ORSAB agar (Oxacillin Resistance Screening Agar Base) Incubate at 37ºC for up to 48 hours Identify and test colonies of S. aureus (see below) Routine isolates All isolates of S. aureus are tested for susceptibility to methicillin using oxacillin 1mg disc on Mueller Hinton agar at 35 C for hours Isolates showing reduced zone size compared to the susceptible control or colonies within the zone should be tested further. Identification and Testing of MRSA Confirm as S. aureus by repeat coagulase test DNAse test Disc susceptibility to oxacillin co-trimoxazole penicillin linezolid erythromycin quinupristin clindamycin rifampicin tetracycline ciprofloxacin gentamicin Confirm if necessary as oxacillin resistant by E test (mic mg/l) Phage typing takes place in a reference laboratory. Note: Isolates from patient known to have MRSA need only be confirmed as S. aureus and grow on ORSAB agar (Oxacillin Resistance Screening Agar Base) Reporting The duty doctor and the Infection Control Nurse should be informed as soon as a new case of MRSA is suspected. The first isolate from each patient should be reported Growth of Methicillin resistant Staph. aureus with full susceptibilities. Subsequent isolates should be reported referring to previous specimens for susceptibilities. 14

15 Appendix 5 Discharge, Admission Information / Communication When a known or suspected MRSA patient is due for admission and/or discharge/transfer the following information should be relayed to the receiving establishment: Patient Name (Date of Birth and Identification Number), MRSA Status (Positive sites), Treatment/ Decolonisation Details (date treatment commenced) and any screening undertaken. Communication Channels Patient from: Home / Community Other Hospital / Ward Care Home Information to be given by: Information to be passed to receiving ward prior to admission. GP / District Nurse Ward Staff (Nursing / Medical) ADMISSION Matron / Home / Care Manager or Staff IN-PATIENT HOSPITAL Information to be passed to receiving area prior to discharge / transfer) DISCHARGE / TRANSFER Ward Staff (Nursing / Medical) Patient to: Home / Community Other Hospital / Ward Nursing Home Residential Home Information to be given to: GP / District Nurse Ward Staff (Nursing / Medical) Matron / Staff Home / Care Manager If a patient is identified as being positive after discharge, information must be passed on to the appropriate person by the Infection Control Team. 15

16 16

17 Can it be treated? Appendix 6 Some antibiotics are still effective against MRSA but they are very powerful and may cause side effects. Because of this they are reserved for patients with serious infections such as bone infections and septicaemia (blood poisoning) etc. It is essential that we extend every effort to prevent the spread of this germ rather than depend on treating it with antibiotics. For further advice regarding MRSA please contact the trained ward staff, or the Home Manager MRSA (Methicillin Resistant Staphylococcus Aureus) NHS Grampian Area Control of Infection Committee May 2003 Patient/Relative Information Leaflet Issued by the Health Protection Team Grampian NHS Board Summerfield House, 2 Eday Road Aberdeen AB15 6RE Tel Fax Grampian NHS Board Grampian University Hospitals NHS Trust Grampian Primary Care NHS Trust

18 What is MRSA? Is MRSA harmful? What precautions should be taken MRSA is a germ (a bacterium called Staphylococcus aureus) which has become resistant to many antibiotics normally used to treat infections. This has happened in part as a result of inappropriate use of antibiotics over the last 30 years or so. Staphylococcus aureus can normally be found on the skin, the groin area, and in the nose and throat and for the most part causes no problems. Under certain circumstances Staphylococcus aureus (and MRSA) can be pathogenic which means that it is able to cause infection. How does it spread? MRSA is like any Staphylococcus aureus in that it can be carried in the nose, throat, skin and in the groin areas without causing infection. This is called colonisation. MRSA is generally spread on the hands when hands are not thoroughly washed. The germs can be spread from the nose and throat for example through coughing, sneezing. MRSA can also survive in the environment in dust that is largely made up of human skin scales. If dust is allowed to collect the germ can survive for long periods and it is possible for staff and patients to become colonised from this source. MRSA is extremely unlikely to cause problems in healthy people living at home. Many people are unaffected by Staphylococcus aureus, but when symptoms are present they usually take the form of boils, wound infections and urinary tract infections (particularly in patients with a catheter). In hospital it is necessary to prevent the spread of MRSA to areas where seriously ill patients are cared for due to the difficulty of treating the infection with antibiotics. The reason that MRSA causes no problems in some people and infection in others is unclear but is probably related to additional underlying medical conditions, eg after an operation. For this reason the presence of MRSA in hospitals is taken more seriously. Fit, healthy individuals are unlikely to develop an infection caused by MRSA and if they do it is likely to be a mild wound infection which would probably clear up spontaneously without antibiotics. Household and personal laundry During your stay in hospital we would ask that all your personal laundry is taken home to be washed. At home all laundry should be washed at the hottest temperature possible for the fabric. Laundry does not need to be washed separately. As always, hands should thoroughly washed after handling soiled laundry. Thorough handwashing, ensuring the web spaces and finger tips are cleaned, with soap and water followed by careful hand drying after visiting the toilet and before skin to skin contact with hospital patients contact with surfaces which may have MRSA on them, eg. wound dressings handling catheters or catheter bags visiting ill patients in hospital handling catheters or catheter bags feeding the very young and elderly All surfaces should be dusted regularly using a damp cloth to prevent the build up of dust Soiled dressings should be placed in a plastic bag for disposal and hands washed thoroughly. 18

19 I m pregnant, will it harm my baby? Appendix 7 MRSA is no more likely to harm a baby in the uterus (or out of it) than any other Staph.aureus. These organisms are carried on the skin by a considerable proportion of the population and are not associated with damage to or loss of the foetus. What about my family? Family members at home are at no more risk of acquiring infection, no matter what their age, from MRSA than from ordinary Staph. aureus that many of them will be carrying. Because they are not exposed to the antibiotic selection pressures of hospitals the y are very unlikely to become colonised with MRSA. For further advice regarding MRSA contact your Infection Control Nurse. NHS Grampian Area Control of Infection Committee May 2003 MRSA (Methicillin Resistant Staphylococcus Aureus) Staff Information Leaflet Issued by the Health Protection Team Grampian NHS Board Summerfield House, 2 Eday Road Aberdeen AB15 6RE Tel Fax Grampian NHS Board Grampian University Hospitals NHS Trust Grampian Primary Care NHS Trust 19

20 What is MRSA? MRSA is Staphylococcus aureus resistant to all β lactam As a result drugs of heavy including, use of antibiotics methicillin, over flucloxacillin, penicillins, cephalosporins and all related drugs. Some strains are, in addition, resistant to other groups of antibiotics such as Macrolides (eg Erythromycin), Aminoglycosides (eg Gentamicin) and Quinolones (eg Ciprofloxacin) Where has MRSA come from? As a result of heavy use of antibiotics over the last 30 years or so some strains of Staph.aureus have become resistant to many antibiotics. The continued use of antibiotics results in these resistant strains being selected out in hospital bacterial populations. Does it matter? There is no difference between MRSA and ordinary Staph.aureus - both are potentially pathogenic ie able to cause infection. However when MRSA does cause an infection this can be very difficult to treat because it is resistant to most available antibiotics. Often the only agent active against MRSA is Vancomycin that has to be given intravenously and is potentially toxic. It is therefore better to control the spread of this organism, and minimise the risk of patients developing an infection. How does it spread? MRSA is like any Staph.aureus. It can be carried in the nose, throat and/or on the skin of people without causing any infection (colonisation). Failure to follow normal hygiene procedures such as washing hands after examining a patient or changing dressings etc. may result in spread of the organism, on the hands, to other patients. MRSA can also survive in the environment. Dust is largely made up of human skin scales, ordinary Staph.aureus and MRSA can be shed from carriers on these skin scales and survive for long periods if dust is allowed to collect. It is possible that patients and staff may then become colonised from this source. Some people are heavy shedders of Staph.aureus. If the strain they carry is MRSA this may be the source of the spread of the organism. Even with good hygiene practice if an individual member of staff carried MRSA in their nose they may spread the organisms to patients while examining them or changing dressings. How do I stop MRSA spreading? How do I stop MRSA spreading? As the As most the likely most way likely of way spreading of spreading MRSA MRSA is on is your on hands, your thorough hands, hand thorough washing hand using washing soap using and water soap followed and by water careful followed hand drying by careful after hand any contact drying after with patients any or potentially contact with contaminated patients surfaces, or potentially is the best way contaminated to minimise surfaces, the risk of is spread. the best It way is also to important minimise to clean the (damp risk of dust) spread. all horizontal It is also important surfaces, push buttons to clean etc (damp regularly dust) to prevent all horizontal build up surfaces, of dust where push MRSA buttons (or ordinary etc regularly Staph.aureus) to prevent may build persist. up of dust where MRSA (or ordinary Staph.aureus) may persist. What type of infections does it cause? MRSA is likely to cause the same type of infections as ordinary Staph.aureus. These are usually infections of the skin such as wound infections or boils. Occasionally it may cause urinary tract infections and more rarely may cause deep infections such as abscesses, bone infections or septicaemia. It is this last group in particular that can be extremely difficult to treat. Will MRSA harm me? Fit healthy individuals are unlikely to develop infections due to MRSA. It they do they will most probably be superficial wound infections which often clear without antibiotics anyway. There is concern about hospital inpatients developing infections because they are already unwell and debilitated and therefore more likely to acquire infection. Also they may be subjected to invasive procedures such as catheterisation which increases the risk of infection. Finally patients are often receiving antibiotics which, by killing their normal bacteria, allow resistant organisms such as MRSA to colonise their skin. 20

21 Appendix 8 Definitions Colonisation Infection Systemic Agar colonisation is when the organism lives harmlessly on the body with no ill effects is when the organism penetrates tissue and causes disease (usually when the skin is breached e.g. due to surgery, or when the immune system is impaired e.g. due to an underlying medical condition). relating to or affecting the body as a whole, rather than individual part and organs gel medium to used to culture bacteria NB The majority of MRSA carriers are colonised as opposed to infected 21

A patient s guide to. MRSA - Methicillin Resistant Staphylococcus Aureus

A patient s guide to. MRSA - Methicillin Resistant Staphylococcus Aureus A patient s guide to MRSA - Methicillin Resistant Staphylococcus Aureus 1 What is MRSA? There are lots of micro-organisms (germs) on our skin. They are in the air we breathe, the water we drink, and the

More information

MRSA CROSS INFECTION RISK: IS YOUR PRACTICE CLEAN ENOUGH?

MRSA CROSS INFECTION RISK: IS YOUR PRACTICE CLEAN ENOUGH? Vet Times The website for the veterinary profession https://www.vettimes.co.uk MRSA CROSS INFECTION RISK: IS YOUR PRACTICE CLEAN ENOUGH? Author : CATHERINE F LE BARS Categories : Vets Date : February 25,

More information

Advice for those affected by MRSA outside of hospital If you have MRSA this booklet provides information to help manage your day-to-day life

Advice for those affected by MRSA outside of hospital If you have MRSA this booklet provides information to help manage your day-to-day life Registered Charity No 1115672 raising public awareness - campaigning for safe standards supporting sufferers and dependants Patron: Edwina Currie President: Professor Hugh Pennington Advice for those affected

More information

About MRSA. MRSA (sometimes referred to as a superbug) stands for meticillin resistant Staphylococcus aureus.

About MRSA. MRSA (sometimes referred to as a superbug) stands for meticillin resistant Staphylococcus aureus. About MRSA Other formats If you need this information in another format such as audio tape or computer disk, Braille, large print, high contrast, British Sign Language or translated into another language,

More information

Advice for those affected by MRSA outside of hospital

Advice for those affected by MRSA outside of hospital Advice for those affected by MRSA outside of hospital If you have MRSA this leaflet provides information and advice for managing your day-to-day life. 2 About MRSA Understanding the difference between

More information

South Staffordshire and Shropshire Healthcare NHS Foundation Trust

South Staffordshire and Shropshire Healthcare NHS Foundation Trust South Staffordshire and Shropshire Healthcare NHS Foundation Trust Document Version Control Document Type and Title: Authorised Document Folder: New or Replacing: Document Reference: Version No. v1.0 Policy

More information

MRSA Screening (Elective Patients)

MRSA Screening (Elective Patients) What is MRSA? MRSA stands for Meticillin resistant Staphylococcus aureus. It is a type of Staphylococcus aureus bacteria (germ) that is very resistant to antibiotics so infections due to MRSA can be quite

More information

MRSA Screening Programme National Targeted Rollout. MRSA Screening

MRSA Screening Programme National Targeted Rollout. MRSA Screening National Targeted Rollout. MRSA Screening A resource pack to support the training of healthcare staff 5th February 2010 Xxxx Learning Outcomes Xxxx On completion of this course you should be able to: Give

More information

Living with MRSA Learning how to control the spread of Methicillin-Resistant Staphylococcus Aureus (MRSA)

Living with MRSA Learning how to control the spread of Methicillin-Resistant Staphylococcus Aureus (MRSA) Living with MRSA Learning how to control the spread of Methicillin-Resistant Staphylococcus Aureus (MRSA) IMPORTANT MRSA is a serious infection that can become life-threatening if left untreated. If you

More information

Your Guide to Managing. Multi Drug-resistant Organisms (MDROs)

Your Guide to Managing. Multi Drug-resistant Organisms (MDROs) Agency for Integrated Care 5 Maxwell Road #10-00 Tower Block MND Complex Singapore 069110 Singapore Silver Line: 1800-650-6060 Email: enquiries@aic.sg Website: www.silverpages.sg Facebook: www.facebook.com/carerssg

More information

MRSA Information for patients, staff and relatives

MRSA Information for patients, staff and relatives MRSA Information for patients, staff and relatives MRSA info nov 17.indd 1 17/11/2017 16:18 What is MRSA? MRSA stands for meticillin (M) resistant (R) Staphylococcus (S) aureus (A). It is a variety of

More information

Healthcare-associated infections surveillance report

Healthcare-associated infections surveillance report Healthcare-associated infections surveillance report Methicillin-resistant Staphylococcus aureus (MRSA) Update, Q3 of 2017/18 Summary Table Q3 2017/18 Previous quarter (Q2 2017/18) Same quarter of previous

More information

Protocol for exit-site care and treatment of exit-site infections in peritoneal dialysis CONTROLLED DOCUMENT

Protocol for exit-site care and treatment of exit-site infections in peritoneal dialysis CONTROLLED DOCUMENT CONTROLLED DOCUMENT Protocol for exit-site care and treatment of exit-site infections in peritoneal dialysis CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Guideline Clinical The purpose

More information

HOSPITAL-ACQUIRED INFECTION/MRSA EYERUSALEM KIFLE AND GIFT IMUETINYAN OMOBOGBE PNURSS15

HOSPITAL-ACQUIRED INFECTION/MRSA EYERUSALEM KIFLE AND GIFT IMUETINYAN OMOBOGBE PNURSS15 HOSPITAL-ACQUIRED INFECTION/MRSA EYERUSALEM KIFLE AND GIFT IMUETINYAN OMOBOGBE PNURSS15 INTRODUCTION DEFINITIONS SIGNS AND SYMPTOMS RISK FACTORS DIAGNOSIS COMPLICATIONS PREVENTIONS TREATMENT PATIENT EDUCATION

More information

Management of Meticillin resistant Staphylococcus

Management of Meticillin resistant Staphylococcus SBC Children, Families and Community Health Service Management of Meticillin resistant Staphylococcus aureus (MRSA) Statement of Intent To provide healthcare staff with clear guidelines for the effective

More information

Staph and MRSA Skin Infections Fact Sheet for Schools

Staph and MRSA Skin Infections Fact Sheet for Schools Cape May County Department of Health 4 Moore Road, Cape May Court House, NJ 08210 Staph and MRSA Skin Infections Fact Sheet for Schools What is a staph/mrsa skin infection? Staphylococcus or staph bacteria

More information

Hand washing/hand hygiene reduces the number of microorganisms on the hands and is the most important practice to prevent the spread of infection.

Hand washing/hand hygiene reduces the number of microorganisms on the hands and is the most important practice to prevent the spread of infection. 1. Hand Hygiene Quick Reference Chart Hand washing/hand hygiene reduces the number of microorganisms on the hands and is the most important practice to prevent the spread of infection. WHEN Before: Direct

More information

North West Neonatal Operational Delivery Network Working together to provide the highest standard of care for babies and families

North West Neonatal Operational Delivery Network Working together to provide the highest standard of care for babies and families Document Title and Reference : Guideline for the management of multi-drug resistant organisms (MDRO) Main Author (s) Simon Power Ratified by: GM NSG Date Ratified: February 2012 Review Date: March 2017

More information

Multi-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED Printed copies must not be considered the definitive version

Multi-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED Printed copies must not be considered the definitive version Multi-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED 2018 Printed copies must not be considered the definitive version DOCUMENT CONTROL POLICY NO. IC-122 Policy Group Infection Control

More information

Antibiotic-resistant Staphylococcus aureus in dermatology and burn wards

Antibiotic-resistant Staphylococcus aureus in dermatology and burn wards J. clin. Path., 1977, 30, 40-44 Antibiotic-resistant Staphylococcus aureus in dermatology and burn wards G. A. J. AYLIFFE, WENDA GREEN, R. LIVINGSTON, AND E. J. L. LOWBURY From the Hospital Infection Research

More information

Multi-Drug Resistant Organisms (MDRO)

Multi-Drug Resistant Organisms (MDRO) Multi-Drug Resistant Organisms (MDRO) 2016 What are MDROs? Multi-drug resistant organisms, or MDROs, are bacteria resistant to current antibiotic therapy and therefore difficult to treat. MDROs can cause

More information

Carbapenemase-Producing Enterobacteriaceae Multi Drug Resistant Organism Management Procedure. (IPC Manual)

Carbapenemase-Producing Enterobacteriaceae Multi Drug Resistant Organism Management Procedure. (IPC Manual) Carbapenemase-Producing Enterobacteriaceae Multi Drug Resistant Organism Management Procedure (IPC Manual) DOCUMENT CONTROL: Version: 1 Ratified by: Clinical Policies Review and Approval Group Date ratified:

More information

Version Control Sheet

Version Control Sheet PROCEDURE FOR MANAGEMENT OF PATIENTS WITH MULTI DRUG RESISTANT ORGANISMS PROCEDURE NUMBER IC/02 DATE RATIFIED OCTOBER 2018 NEXT REVIEW DATE OCTOBER 2020 POLICY AUTHOR Infection Control Nurse ACCOUNTABLE

More information

Antibiotic Prophylaxis in Spinal Surgery Antibiotic Guidelines. Contents

Antibiotic Prophylaxis in Spinal Surgery Antibiotic Guidelines. Contents Antibiotic Prophylaxis in Spinal Antibiotic Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): Authors Division: DCSS & Tertiary Medicine Unique

More information

Screening for MRSA / MSSA and CPO within the Kent Kidney Care Centre

Screening for MRSA / MSSA and CPO within the Kent Kidney Care Centre Screening for MRSA / MSSA and CPO within the Kent Kidney Care Centre Information for patients from the Infection Prevention and Control Team and the Renal Team This leaflet is not meant to replace the

More information

Invasive Group A Streptococcus (GAS)

Invasive Group A Streptococcus (GAS) Invasive Group A Streptococcus (GAS) Cause caused by a bacterium commonly found on the skin and in the throat transmitted by direct, indirect or droplet contact with secretions from the nose, and throat

More information

MRSA What We Need to Know Sharon Pearce, CRNA, MSN Carolina Anesthesia Associates

MRSA What We Need to Know Sharon Pearce, CRNA, MSN Carolina Anesthesia Associates MRSA What We Need to Know Sharon Pearce, CRNA, MSN Carolina Anesthesia Associates What is MRSA? Methicillin-resistant Staphylococus aureus This hardy bacterium has developed resistance to every antibiotic

More information

Methicillin Resistant Staphylococcus aureus:

Methicillin Resistant Staphylococcus aureus: Methicillin Resistant Staphylococcus aureus: Action-Oriented Guidance for Community-Based Prevention Jackie Dawson, PhD Public Health Epidemiologist Chelan, Douglas, Grant, Kittitas, & Okanogan Counties

More information

Health Service Executive Parkgate St. Business Centre, Dublin 8 Tel:

Health Service Executive Parkgate St. Business Centre, Dublin 8 Tel: Health Service Executive Parkgate St. Business Centre, Dublin 8 Tel: 01 635 2500 www.hse.ie Health Service Executive Oak House, Millennium Park, Naas, Co. Kildare Tel: 045 880 400 www.hse.ie The prevention

More information

Risk factors? Insect bites? Hygiene? Household crowding Health literacy

Risk factors? Insect bites? Hygiene? Household crowding Health literacy Recurrent boils Commonest sites face, neck, armpits, shoulders, and buttocks (bottom) infection of the hair root or sweat pore Occur in otherwise healthy people (higher rates in diabetics, eczema, iron

More information

GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS

GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS Version 3.1 GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS Date ratified June 2008 Updated March 2009 Review date June 2010 Ratified by Authors Consultation Evidence base Changes

More information

Replaces:04/14/16. Formulated: 1997 SKIN AND SOFT TISSUE INFECTION

Replaces:04/14/16. Formulated: 1997 SKIN AND SOFT TISSUE INFECTION Effective Date: 04/13/17 Replaces:04/14/16 Page 1 of 7 POLICY To standardize the clinical management and housing of offenders with skin and soft tissue infections, thereby reducing the transmission and

More information

Glycopeptide Resistant Enterococci (GRE) Policy IC/292/10

Glycopeptide Resistant Enterococci (GRE) Policy IC/292/10 BASINGSTOKE AND NORTH HAMPSHIRE NHS FOUNDATION TRUST Glycopeptide Resistant Enterococci (GRE) Policy IC/292/10 Supersedes: IC/292/07 Owner Name Dr Nicki Hutchinson Job Title Consultant Microbiologist,

More information

MRSA: How to Keep This Deadly Super Bug From Infecting You

MRSA: How to Keep This Deadly Super Bug From Infecting You MRSA: How to Keep This Deadly Super Bug From Infecting You DR. MERCOLA $9.97 Mercola.com is the world s #1-ranked natural health website, with over one million subscribers to its free newsletter. Millions

More information

MRSA in the United Kingdom status quo and future developments

MRSA in the United Kingdom status quo and future developments MRSA in the United Kingdom status quo and future developments Dietrich Mack Chair of Medical Microbiology and Infectious Diseases The School of Medicine - University of Wales Swansea P R I F Y S G O L

More information

COMMUNITY ASSOCIATED METHICILLIN-RESISTANT STAPHLOCOCCUS AUREUS A PRACTICAL GUIDE FOR PRIMARY CARE PRACTITIONERS

COMMUNITY ASSOCIATED METHICILLIN-RESISTANT STAPHLOCOCCUS AUREUS A PRACTICAL GUIDE FOR PRIMARY CARE PRACTITIONERS COMMUNITY ASSOCIATED METHICILLIN-RESISTANT STAPHLOCOCCUS AUREUS A PRACTICAL GUIDE FOR PRIMARY CARE PRACTITIONERS December 21, 2010 Background Since it was first described in 1961 methicillin resistant

More information

Today s Agenda: 9/30/14

Today s Agenda: 9/30/14 Today s Agenda: 9/30/14 1. Students will take C List Medical Abbreviation Quiz. 2. TO: Discuss MRSA. MRSA MRSA Methicillin Resistant Staphylococcus Aureus Methicillin Resistant Staphylococcus Aureus What

More information

Cellulitis. Assoc Prof Mark Thomas. Conference for General Practice Auckland Saturday 28 July 2018

Cellulitis. Assoc Prof Mark Thomas. Conference for General Practice Auckland Saturday 28 July 2018 Cellulitis Assoc Prof Mark Thomas Conference for General Practice Auckland Saturday 28 July 2018 Summary Cellulitis Usual treatment flucloxacillin for 5 days Frequent recurrences consider penicillin 250mg

More information

To guide safe and appropriate selection of antibiotic therapy for Peritoneal Dialysis patients.

To guide safe and appropriate selection of antibiotic therapy for Peritoneal Dialysis patients. Nephrology Directorate Subject: Objective: Prepared by: Aintree Antibiotic Guidelines for Peritoneal Dialysis (PD): Catheter Insertion, and the Diagnosis and Treatment of PD Peritonitis and Exit-Site Infections.

More information

In-Service Training Program. Managing Drug-Resistant Organisms in Long-Term Care

In-Service Training Program. Managing Drug-Resistant Organisms in Long-Term Care In-Service Training Program Managing Drug-Resistant Organisms in Long-Term Care OBJECTIVES 1. Define the term antibiotic resistance. 2. Explain the difference between colonization and infection. 3. Identify

More information

Methicillin-Resistant Staphylococcus aureus

Methicillin-Resistant Staphylococcus aureus Methicillin-Resistant Staphylococcus aureus By Karla Givens Means of Transmission and Usual Reservoirs Staphylococcus aureus is part of normal flora and can be found on the skin and in the noses of one

More information

Role of the nurse in diagnosing infection: The right sample, every time

Role of the nurse in diagnosing infection: The right sample, every time BROUGHT TO YOU BY Role of the nurse in diagnosing infection: The right sample, every time The module has been written by Shanika Anne-Marie Crusz and Amelia Joseph Authors affiliation: Department of Clinical

More information

2.0 Scope These guidelines refer to all Cheshire Ireland employees, service users, their relatives, carers and visitors.

2.0 Scope These guidelines refer to all Cheshire Ireland employees, service users, their relatives, carers and visitors. Status: Guideline: Offers direction and guidance on good practice, need not necessarily be strictly adhered to. Title: Guidelines for Hand Hygiene Written by: Clinical Practice Project Group Policy No:

More information

Treatment of Surgical Site Infection Meeting Quality Statement 6. Prof Peter Wilson University College London Hospitals

Treatment of Surgical Site Infection Meeting Quality Statement 6. Prof Peter Wilson University College London Hospitals Treatment of Surgical Site Infection Meeting Quality Statement 6 Prof Peter Wilson University College London Hospitals TEG Quality Standard 6 Treatment and effective antibiotic prescribing: People with

More information

Questions and answers about methicillin-resistant Staphylococcus aureus (MRSA)

Questions and answers about methicillin-resistant Staphylococcus aureus (MRSA) Questions and answers about methicillin-resistant Staphylococcus aureus (MRSA) Updated FAQ, 18 November 2014 Methicillin-resistant Staphylococcus aureus (MRSA) are bacteria which are resistant to certain

More information

Responders as percent of overall members in each category: Practice: Adult 490 (49% of 1009 members) 57 (54% of 106 members)

Responders as percent of overall members in each category: Practice: Adult 490 (49% of 1009 members) 57 (54% of 106 members) Infectious Diseases Society of America Emerging Infections Network 6/2/10 Report for Query: Perioperative Staphylococcus aureus Screening and Decolonization Overall response rate: 674/1339 (50.3%) physicians

More information

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times Safe Patient Care Keeping our Residents Safe 2016 Use Standard Precautions for ALL Residents at ALL times #safepatientcare Do bugs need drugs? Dr Deirdre O Brien Consultant Microbiologist Mercy University

More information

Healthcare-associated infections surveillance report

Healthcare-associated infections surveillance report Healthcare-associated infections surveillance report Methicillin-resistant Staphylococcus aureus (MRSA) Update, Q4 2015/16 Summary Table Q4 2015/2016 Previous quarter (Q3 2015/16) Same quarter of previous

More information

REVIEW DATE October 2009

REVIEW DATE October 2009 POLICY TITLE Pets POLICY REFERENCE NUMBER ICP20 DATE OF ISSUE March 2005 DATE OF IMPLEMENTATION October 2007 DEVELOPED / REVIEWED BY Nursing REVIEW DATE October 2009 RESPONSIBLE DIRECTOR Director of Nursing

More information

Kevin Chapman Infection, Prevention and Control Nurse Ron Forbister Patient Safety Officer. Contents

Kevin Chapman Infection, Prevention and Control Nurse Ron Forbister Patient Safety Officer. Contents Infection, Prevention and Control Practice Guidance Note Animals in Healthcare Environment V01 Date Issued Issue 1- Sept 14 Issue 2 Nov 16 Issue 3 Sep 17 Planned review March 2018 IPC-PGN-29 Part of NTW(C)23,

More information

Approval Signature: Original signed by Dr. Michel Tetreault Date of Approval: July Review Date: July 2017

Approval Signature: Original signed by Dr. Michel Tetreault Date of Approval: July Review Date: July 2017 WRHA Infection Prevention and Control Program Operational Directives Admission Screening for Antibiotic Resistant Organisms (AROs): Methicillin Resistant Staphylococcus aureus (MRSA) and Vancomycin Resistant

More information

Who should read this document 2. Key practice points 2. Background/ Scope/ Definitions 2. What is new in this version 3. Policy/Procedure/Guideline 3

Who should read this document 2. Key practice points 2. Background/ Scope/ Definitions 2. What is new in this version 3. Policy/Procedure/Guideline 3 Antibiotic Prophylaxis in Cranial Neurosurgery Antibiotic Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): as above Authors Division: DCSS & Tertiary

More information

Women s Antimicrobial Guidelines Summary

Women s Antimicrobial Guidelines Summary Women s Antimicrobial Guidelines Summary 1. Introduction and Who Guideline applies to This guideline has been developed to deliver safe and appropriate empirical use of antibiotics for patients at University

More information

Infection Control and Standard Precautions

Infection Control and Standard Precautions Home Care Aide Training Guide Infection Control and Standard Precautions Pre-Service Training Course #1 Home Care Aide Orientation Training Manual: Infection Control & Standard Precautions Page 2 Table

More information

Intro Who should read this document 2 Key practice points 2 Background 2

Intro Who should read this document 2 Key practice points 2 Background 2 Antibiotic Guidelines: Obstetric Anti-Infective Prescribing Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): Kelly Alexander / Frances Garraghan

More information

So Why All the Fuss About Hand Hygiene?

So Why All the Fuss About Hand Hygiene? CARING PROFESSIONAL SERVICES, INC. HAND HYGIENE In-Service So Why All the Fuss About Hand Hygiene? Most common mode of transmission of pathogens is via hands! Infections acquired in healthcare Spread of

More information

Symptoms of cellulitis (n=396) %

Symptoms of cellulitis (n=396) % Cellulitis and lymphoedema Vaughan Keeley May 2012 What is cellulitis? - also called erysipelas, acute inflammatory episodes etc. - bacterial infection of skin + subcutaneous tissues - more common in people

More information

PVL Staph aureusjust a skin/soft tissue problem? Layla Mohammadi Lead Pharmacist, Antimicrobials Lewisham Healthcare NHS Trust

PVL Staph aureusjust a skin/soft tissue problem? Layla Mohammadi Lead Pharmacist, Antimicrobials Lewisham Healthcare NHS Trust PVL Staph aureusjust a skin/soft tissue problem? Layla Mohammadi Lead Pharmacist, Antimicrobials Lewisham Healthcare NHS Trust Neonatal Case History Neonate born at 26 +2 gestation Spontaneous onset of

More information

MRSA. Patient Screening Information

MRSA. Patient Screening Information MRSA Patient Screening Information WHAT IS MRSA? First identified in the 1960s, MRSA is an abbreviation of Meticillin Resistant Staphylococcus Aureus. MRSA is a bacteria that has developed resistance to

More information

Conflict of interest: We have no conflict of interest to report on this topic of SSI reduction for total knees.

Conflict of interest: We have no conflict of interest to report on this topic of SSI reduction for total knees. Reducing SSI- Knees TIFFANY KENNERK MBA, MSN, RN, NE -BC, ONC CYNTHIA SEAMAN BSN, RN, ONC, CMSRN ~COMMUNITY HOSPITALS AND WELLNESS CENTERS~ Conflict of interest: We have no conflict of interest to report

More information

Antimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018

Antimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018 Antimicrobial Update Alison MacDonald Area Antimicrobial Pharmacist NHS Highland alisonc.macdonald@nhs.net April 2018 Starter Questions Setting the scene... What if antibiotics were no longer effective?

More information

Doxycycline staph aureus

Doxycycline staph aureus Search Search Doxycycline staph aureus Mercer infection is the one of the colloquial terms given for MRSA (Methicillin-Resistant Staphylococcus Aureus ) infection. Initially, Staphylococcal resistance

More information

Draft Guidelines for the Control of Methicillin- Resistant Staphylococcus Aureus in New Zealand

Draft Guidelines for the Control of Methicillin- Resistant Staphylococcus Aureus in New Zealand Draft Guidelines for the Control of Methicillin- Resistant Staphylococcus Aureus in New Zealand Draft Guidelines for the Control of Methicillin-Resistant Staphylococcus aureus in New Zealand were developed

More information

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility ANTIMICROBIAL SUSCEPTIBILITY TESTING ON MILK SAMPLES Method and guidelines There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

More information

Antimicrobial Update Stewardship in Primary Care. Clare Colligan Antimicrobial Pharmacist NHS Forth Valley

Antimicrobial Update Stewardship in Primary Care. Clare Colligan Antimicrobial Pharmacist NHS Forth Valley Antimicrobial Update Stewardship in Primary Care Clare Colligan Antimicrobial Pharmacist NHS Forth Valley Setting the Scene! Consequences of Antibiotic Use? Resistance For an individual patient with

More information

Infection Control Manual Residential Care Part 3 Infection Control Standards IC7: 0100 Methicillin Resistant Staphylococcus aureus

Infection Control Manual Residential Care Part 3 Infection Control Standards IC7: 0100 Methicillin Resistant Staphylococcus aureus Infection Control Manual Residential Care Part 3 Infection Control Standards IC7: 0100 Methicillin Resistant Staphylococcus aureus IC7: 0100 MRSA 1. Purpose To outline the assessment, management, room

More information

Methicillin Resistant Staphylococcus Aureus (MRSA) Achievement in Al-Mafraq Hospital Abu Dhabi, UAE

Methicillin Resistant Staphylococcus Aureus (MRSA) Achievement in Al-Mafraq Hospital Abu Dhabi, UAE Methicillin Resistant Staphylococcus Aureus (MRSA) Achievement in Al-Mafraq Hospital Abu Dhabi, UAE By: Mr. Moh d Hamad, Infection Control Officer, April, 2004 25% of the individuals are permanent carrier

More information

ANTIBIOTIC PRESCRIBING POLICY FOR DIABETIC FOOT DISEASE IN SECONDARY CARE

ANTIBIOTIC PRESCRIBING POLICY FOR DIABETIC FOOT DISEASE IN SECONDARY CARE ANTIBIOTIC PRESCRIBING POLICY FOR DIABETIC FOOT DISEASE IN SECONDARY CARE Version 1.0 Date ratified June 2009 Review date June 2011 Ratified by Authors Consultation Nottingham Antibiotic Guidelines Committee

More information

Cork and Kerry SARI Newsletter; Vol. 2 (2), December 2006

Cork and Kerry SARI Newsletter; Vol. 2 (2), December 2006 Cork and SARI Newsletter; Vol. 2 (2), December 6 Item Type Newsletter Authors Murray, Deirdre;O'Connor, Nuala;Condon, Rosalind Download date 31/1/18 15:27:31 Link to Item http://hdl.handle.net/1147/67296

More information

Prevalence & Risk Factors For MRSA. For Vets

Prevalence & Risk Factors For MRSA. For Vets For Vets General Information Staphylococcus aureus is a Gram-positive, aerobic commensal bacterium of humans that is carried in the anterior nares of approximately 30% of the general population. It is

More information

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018 Introduction to Chemotherapeutic Agents Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018 Antimicrobial Agents Substances that kill bacteria without harming the host.

More information

Treatment of peritonitis in patients receiving peritoneal dialysis Antibiotic Guidelines. Contents

Treatment of peritonitis in patients receiving peritoneal dialysis Antibiotic Guidelines. Contents Treatment of peritonitis in patients receiving Antibiotic Guidelines Classification: Clinical Guideline Lead Author: Jude Allen (Pharmacist) Additional author(s): Dr David Lewis, Dr Dimitrios Poulikakos,

More information

Int.J.Curr.Microbiol.App.Sci (2018) 7(1):

Int.J.Curr.Microbiol.App.Sci (2018) 7(1): International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 01 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.701.080

More information

Antimicrobial susceptibility

Antimicrobial susceptibility Antimicrobial susceptibility PATTERNS Microbiology Department Canterbury ealth Laboratories and Clinical Pharmacology Department Canterbury District ealth Board March 2011 Contents Preface... Page 1 ANTIMICROBIAL

More information

Trust Guideline for the Management of: Antibiotic Prophylaxis in adults undergoing procedures in Interventional Radiology

Trust Guideline for the Management of: Antibiotic Prophylaxis in adults undergoing procedures in Interventional Radiology Antibiotic Prophylaxis in adults undergoing procedures in Interventional Radiology A Clinical Guideline For use in: By: For: Division responsible for document: Key words: Interventional Radiology Prescribers

More information

HEALTH SERVICES POLICY & PROCEDURE MANUAL

HEALTH SERVICES POLICY & PROCEDURE MANUAL PAGE 1 of 3 PURPOSE To assure that DOP inmates with Soft Tissue Infections are receiving high quality Primary Care for their infections and that the risk of infecting other inmates or staff is minimized.

More information

American Association of Feline Practitioners American Animal Hospital Association

American Association of Feline Practitioners American Animal Hospital Association American Association of Feline Practitioners American Animal Hospital Association Basic Guidelines of Judicious Therapeutic Use of Antimicrobials August 1, 2006 Introduction The Basic Guidelines to Judicious

More information

A retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya

A retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya A retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya LU Edirisinghe 1, D Vidanagama 2 1 Senior Registrar in Medicine, 2 Consultant Microbiologist,

More information

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain

More information

Surveillance of Multi-Drug Resistant Organisms

Surveillance of Multi-Drug Resistant Organisms Surveillance of Multi-Drug Resistant Organisms Karen Hoffmann, RN, MS, CIC Associate Director Statewide Program for Infection Control and Epidemiology (SPICE) University of North Carolina School of Medicine

More information

HEALTHY HINTS HEALTHY HINTS

HEALTHY HINTS HEALTHY HINTS HEALTHY HINTS REDUCING SUMMER RISKS FOR YOU AND YOUR PETS It s summer but it s also BUG SEASON!!! Summer is the season to be especially aware and to take the necessary precautions to precent an overload

More information

CORSHAM PRIMARY SCHOOL

CORSHAM PRIMARY SCHOOL CORSHAM PRIMARY SCHOOL Animal Welfare Policy Reviewed: September 2016 Policy Ratified by the Governing Body: September 2015 Next Review Date: September 2017 Animal Welfare Policy 1. Introduction/Background

More information

M R S A. Methicillin-Resistant Staphylococcus aureus. The Facts

M R S A. Methicillin-Resistant Staphylococcus aureus. The Facts M R S A Methicillin-Resistant Staphylococcus aureus The Facts Michael Parry, M.D. Director of Infectious Diseases and Microbiology Stamford Hospital January 24, 2008 Introduction to Staph aureus Staphylococcus

More information

Diagnosis: Presenting signs and Symptoms include:

Diagnosis: Presenting signs and Symptoms include: PERITONITIS TREATMENT PROTOCOL CARI - Caring for Australasians with Renal Impairment - CARI Guidelines complete list ISPD Guidelines: http://www.ispd.org/lang-en/treatmentguidelines/guidelines Objective

More information

appropriate healthcare professionals employed at my pharmacy. I understand that I am

appropriate healthcare professionals employed at my pharmacy. I understand that I am Patient Group Direction: For the supply of Silver Sulfadiazine 1% Cream by Community Pharmacists in Somerset to patients for the topical treatment of minor localised impetigo under the Somerset Minor Ailments

More information

Antibiotic Prophylaxis Update

Antibiotic Prophylaxis Update Antibiotic Prophylaxis Update Choosing Surgical Antimicrobial Prophylaxis Peri-Procedural Administration Surgical Prophylaxis and AMS at Epworth HealthCare Mr Glenn Valoppi Dr Trisha Peel Dr Joseph Doyle

More information

EcoHydra Antimicrobial Handwash. Product Overview. Physical Properties. Product Description. Regulatory Compliance. Key Features and Benefits

EcoHydra Antimicrobial Handwash. Product Overview. Physical Properties. Product Description. Regulatory Compliance. Key Features and Benefits EcoHydra Antimicrobial Handwash Product Overview Product Description The EcoHydra Antimicrobial Handwash is a liquid soap substitute for the wet method of washing and disinfecting to remove dirt and kill

More information

LIVING IN A POST-ANTIBIOTIC ERA: the impact on public health

LIVING IN A POST-ANTIBIOTIC ERA: the impact on public health LIVING IN A POST-ANTIBIOTIC ERA: the impact on public health WELCOME This booklet was created by the Biochemical Society and the Society for General Microbiology as part of a series of public debates around

More information

Neurosurgery Antibiotic Prophylaxis Guideline

Neurosurgery Antibiotic Prophylaxis Guideline Neurosurgery Antibiotic Prophylaxis Guideline Full Title of Guideline: Author (include email and role): Division & Speciality: Scope (Target audience, state if Trust wide): Review date (when this version

More information

number Done by Corrected by Doctor Dr Hamed Al-Zoubi

number Done by Corrected by Doctor Dr Hamed Al-Zoubi number 8 Done by Corrected by Doctor Dr Hamed Al-Zoubi 25 10/10/2017 Antibacterial therapy 2 د. حامد الزعبي Dr Hamed Al-Zoubi Antibacterial therapy Figure 2/ Antibiotics target Inhibition of microbial

More information

Annual survey of methicillin-resistant Staphylococcus aureus (MRSA), 2008

Annual survey of methicillin-resistant Staphylococcus aureus (MRSA), 2008 Annual survey of methicillin-resistant Staphylococcus aureus (MRSA), 2008 Each year ESR conducts a one-month survey of methicillin-resistant Staphylococcus aureus (MRSA) to provide ongoing information

More information

Healthcare-associated Infections Annual Report December 2018

Healthcare-associated Infections Annual Report December 2018 December 2018 Healthcare-associated Infections Annual Report 2011-2017 TABLE OF CONTENTS INTRODUCTION... 1 METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTIONS... 2 MRSA SURVEILLANCE... 3 CLOSTRIDIUM

More information

SURGICAL ANTIBIOTIC PROPHYLAXIS GUIDELINES WITHIN ORTHOPAEDIC SURGERY FOR ADULT PATIENTS

SURGICAL ANTIBIOTIC PROPHYLAXIS GUIDELINES WITHIN ORTHOPAEDIC SURGERY FOR ADULT PATIENTS SURGICAL ANTIBIOTIC PROPHYLAXIS GUIDELINES WITHIN ORTHOPAEDIC SURGERY FOR ADULT PATIENTS Full Title of Guideline: Author (include email and role): Division & Speciality: Scope (Target audience, state if

More information

Importance of handwashing prior to wound dressings in prevention of nosocomial infection in surgical wards

Importance of handwashing prior to wound dressings in prevention of nosocomial infection in surgical wards International Surgery Journal Athavale VS et al. Int Surg J. 218 Apr;5(4):1422-1427 http://www.ijsurgery.com pissn 2349-335 eissn 2349-292 Original Research Article DOI: http://dx.doi.org/1.1823/2349-292.isj2181123

More information

Nosocomial Antibiotic Resistant Organisms

Nosocomial Antibiotic Resistant Organisms Nosocomial Antibiotic Resistant Organisms Course Medical Microbiology Unit II Laboratory Safety and Infection Control Essential Question Does improved hand hygiene really reduce the spread of bacteria

More information

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory

More information

Volume-7, Issue-2, April-June-2016 Coden IJABFP-CAS-USA Received: 5 th Mar 2016 Revised: 11 th April 2016 Accepted: 13 th April 2016 Research article

Volume-7, Issue-2, April-June-2016 Coden IJABFP-CAS-USA Received: 5 th Mar 2016 Revised: 11 th April 2016 Accepted: 13 th April 2016 Research article Volume-7, Issue-2, April-June-2016 Coden IJABFP-CAS-USA Copyrights@2016 Received: 5 th Mar 2016 Revised: 11 th April 2016 Accepted: 13 th April 2016 Research article A STUDY ON ANTIBIOTIC SUSCEPTIBILITY

More information

Int.J.Curr.Microbiol.App.Sci (2018) 7(8):

Int.J.Curr.Microbiol.App.Sci (2018) 7(8): International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 08 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.708.378

More information

Ca-MRSA Update- Hand Infections. Washington Hand Society September 19, 2007

Ca-MRSA Update- Hand Infections. Washington Hand Society September 19, 2007 Ca-MRSA Update- Hand Infections Washington Hand Society September 19, 2007 Resistant Staph. Aureus Late 1940 s -50% S.Aureus resistant to PCN 1957-80/81 strain- of S.A. highly virulent and easily transmissible

More information

SUMMARY OF PRODUCT CHARACTERISTICS. Cephacare flavour 50 mg tablets for cats and dogs. Excipients: For a full list of excipients, see section 6.1.

SUMMARY OF PRODUCT CHARACTERISTICS. Cephacare flavour 50 mg tablets for cats and dogs. Excipients: For a full list of excipients, see section 6.1. SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Cephacare flavour 50 mg tablets for cats and dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: Active

More information